The global neurology devices market was valued at USD 15.98 billion in 2024, grew to USD 17.28 billion in 2025, and is expected to reach USD 34.76 billion by 2034. This reflects a strong CAGR of 8.14% from 2025 to 2034.
The rising prevalence of central and peripheral nervous system disorders is the primary market driver. Governments worldwide are launching awareness programs for early screening and diagnosis. In addition, strategic collaborations between industry leaders are accelerating innovation, particularly in wearable neuro devices and AI‑based diagnostic tools.
Market Size 2024: USD 15.98 Billion
Forecast 2034: USD 34.76 Billion
CAGR (2025‑2034): 8.14%
North America Market Share 2024: ~41%
Asia-Pacific Growth Rate: Fastest growing region during forecast period
Leading Product Segment 2024: Neurostimulation Devices (~34% market share)
Fastest Growing Product Segment: Interventional Neurology Devices
About: Medtronic, headquartered in Ireland, is a global leader in medical technology, including advanced neurology solutions.
Products: Deep brain stimulation (DBS) systems, neurostimulators, and pain management devices.
Market Cap: Approx. USD 110 billion.
About: A U.S.-based medical device manufacturer with a strong neurology portfolio.
Products: Neuromodulation devices, spinal cord stimulators, and interventional neurology solutions.
Market Cap: Approx. USD 92 billion.
About: A diversified healthcare company with expertise in neuromodulation and diagnostics.
Products: Deep brain stimulation devices, vagus nerve stimulation systems.
Market Cap: Approx. USD 192 billion.
About: Stryker is a global medical technology leader specializing in surgical and neurovascular solutions.
Products: Neurovascular devices, clot retrieval systems, and navigation platforms.
Market Cap: Approx. USD 130 billion.
About: A leading U.S. medical device company focused on neurovascular and peripheral vascular solutions.
Products: Stroke thrombectomy devices, aspiration catheters.
Market Cap: Approx. USD 8 billion.
About: U.S.-based company specializing in neurostimulation for epilepsy treatment.
Products: Responsive Neurostimulation (RNS) system.
Market Cap: Approx. USD 150 million.
About: Specializes in neurodiagnostic and monitoring solutions.
Products: EEG systems, sleep diagnostic devices, EMG equipment.
Market Cap: Privately held (acquired by ArchiMed).
About: Global medical technology company with strong neuromodulation expertise.
Products: Vagus nerve stimulation devices for epilepsy and depression.
Market Cap: Approx. USD 2.4 billion.
About: Renowned for musculoskeletal healthcare solutions, with a neurosurgical product line.
Products: Cranial stabilization systems, neurosurgical instruments.
Market Cap: Approx. USD 25 billion.
About: U.S.-based surgical and regenerative technologies provider.
Products: Neurosurgical instruments, dural repair products.
Market Cap: Approx. USD 3.5 billion.
About: German company specializing in polymer-based medical devices.
Products: Intracranial pressure monitoring devices, catheters.
Market Cap: Private company.
About: Focuses on trigeminal nerve stimulation for neurological disorders.
Products: Monarch eTNS system for ADHD and epilepsy.
Market Cap: Private company.
About: A global leader in medical imaging and monitoring.
Products: Advanced MRI, CT, and PET scanners for neuroimaging.
Market Cap: Approx. USD 32 billion.
About: Dutch multinational in healthcare technology.
Products: Neuroimaging systems, EEG monitoring devices.
Market Cap: Approx. USD 20 billion.
About: Leading medical device manufacturer with a neurosurgical division.
Products: Neurovascular access products, aneurysm treatment devices.
Market Cap: Approx. USD 360 billion.
About: Specializes in neurostimulation for respiratory function recovery.
Products: NeuRx Diaphragm Pacing System.
Market Cap: Private company.
About: Israeli company focused on ischemic stroke therapy.
Products: Electrical stimulation devices for cerebral blood flow improvement.
Market Cap: Private company.
About: U.S.-based innovator in thin-film electrode technology.
Products: Cortical and depth electrode devices for neurological diagnostics.
Market Cap: Approx. USD 30 million.
About: Known for diagnostic and surgical solutions.
Products: Neurological biopsy systems for brain tissue sampling.
Market Cap: Approx. USD 16 billion.
About: Specializes in wearable neurostimulation technology.
Products: Electrical muscle stimulation suits for rehabilitation and performance.
Market Cap: Private company.
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
Q1. What is driving the growth of the neurology devices market?
The market is driven by the increasing prevalence of neurological disorders, technological advancements, and growing awareness for early diagnosis.
Q2. Which region holds the largest share in the neurology devices market?
North America dominates the market, holding approximately 41% share in 2024.
Q3. What is the fastest-growing region in this market?
Asia-Pacific is expected to grow at the fastest rate due to rising healthcare investments and increasing incidence of neurological diseases.
Q4. Which product type dominates the neurology devices market?
Neurostimulation devices hold the largest share, accounting for around 34% of the market in 2024.
Q5. Who are the top companies in the neurology devices industry?
Key players include Medtronic, Boston Scientific, Abbott, Stryker, Penumbra, NeuroPace, and others.
Source : https://www.towardshealthcare.com/insights/neurology-devices-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5923
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More
The Direct-To-Consumer Genetic Testing Market is witnessing a global transformation, driven by the growing consumer demand for personalized healthcare insights.… Read More
The global digital health market is witnessing a steady rise and much of it is driven by the increasing number… Read More
In 2025, North America emerged as the clear frontrunner in the healthcare Contract Research Organization (CRO) market and it’s easy… Read More
Powering the Future of Cell and Gene Therapy Virocell Biologics, a leading name in vector manufacturing for cell and gene… Read More